Beximco Pharmaceuticals PLC. (AIM:BXP)
London · Delayed Price · Currency is GBP · Price in GBX 42.50
0.00 (0.00%)
Dec 31, 2025, 12:44 PM GMT+1
AIM:BXP Market Cap
AIM:BXP has a market cap or net worth of 276.33 million as of December 31, 2025. Its market cap has increased by 11.95% in one year.
Market Cap
276.33M
Enterprise Value
320.67M
Revenue
309.11M
Ranking
n/a
PE Ratio
6.52
Stock Price
42.50
Market Cap Chart
Since January 3, 2000, AIM:BXP's market cap has increased from 22.96M to 276.33M, an increase of 1,103.43%. That is a compound annual growth rate of 10.04%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 1, 2026 | 276.04M | -0.21% |
| Dec 30, 2025 | 276.63M | 14.11% |
| Dec 30, 2024 | 242.42M | -48.09% |
| Dec 28, 2023 | 466.99M | -11.21% |
| Dec 29, 2022 | 525.95M | -29.56% |
| Dec 30, 2021 | 746.62M | 1.29% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 213.19B |
| GSK plc | 73.15B |
| Haleon | 33.22B |
| Smith & Nephew | 10.43B |
| Convatec Group | 4.74B |
| Hikma Pharmaceuticals | 3.40B |
| Genus | 1.73B |
| HUTCHMED (China) | 1.71B |